Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer

NCT04814407 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04814407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2021
Completion date
December 31, 2027
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer